Starling Oncology (STLN) Stock Insights
$661.39M
Market Cap
—
P/E
—
Forward P/E
—
Score
STLN price $6.62 +0.03 +0.38%
STLN fair value $3.52. Price $6.62. Price is 88% above fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-08-06 | -0.08 | -0.06 | 161.28M | 155.74M |
| 2026-05-07 | -0.02 | -0.09 | 147.44M | 142.10M |
| 2025-08-13 | -0.15 | -0.12 | 119.80M | 113.32M |
| 2025-05-14 | -0.21 | — | 104.41M | — |
| 2024-08-13 | -0.17 | -0.09 | 98.60M | 103.31M |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-08-21 | Hively Brad | Sell | 298.85K | $6.51 | 1.95M |
| 2026-08-14 | Chernett Jorey | Buy | 12.00K | $6.54 | 78.48K |
| 2026-08-13 | Chernett Jorey | Sell | 100 | $9.00 | 900 |
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| No data yet. | ||||
Insights · Dividends · Forecast · Financials · Learn
$661.39M
Market Cap
—
P/E
—
Forward P/E
—
Score